Assessing the Likelihood of Gastrointestinal Complications in Patients with Lymphoma: A Propensity Score Analysis - Scorecard - MDSpire

Assessing the Likelihood of Gastrointestinal Complications in Patients with Lymphoma: A Propensity Score Analysis

  • By

  • Yahan Zhao

  • Xuchen Zhang

  • Yuanzhi Zhou

  • Nan Dai

  • Yarui Li

  • Shuixiang He

  • March 3, 2026

  • 0 min

Share

Clinical Scorecard: Assessing the Likelihood of Gastrointestinal Complications in Patients with Lymphoma: A Propensity Score Analysis

At a Glance

CategoryDetail
ConditionPrimary gastrointestinal lymphoma as defined by the source.
Key Mechanisms
Target Population
Care Setting

Key Highlights

  • statistic_source

Guideline-Based Recommendations

Diagnosis

    Management

    • I
    • n
    • c
    • l
    • u
    • d
    • e
    • s
    • p
    • e
    • c
    • i
    • f
    • i
    • c
    • t
    • r
    • e
    • a
    • t
    • m
    • e
    • n
    • t
    • o
    • p
    • t
    • i
    • o
    • n
    • s
    • f
    • o
    • r
    • G
    • I
    • C
    • s
    • .

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Detail the types of chemotherapy, radiotherapy, or surgery used.

        Clinical Best Practices

        • examples

        References

        Original Source(s)

        Assessing the Likelihood of Gastrointestinal Complications in Patients with Lymphoma: A Propensity Score Analysis

        • by Yahan Zhao, Xuchen Zhang, Yuanzhi Zhou, Nan Dai, Yarui Li, Shuixiang He

        • March 3, 2026

        Related Content

        Roswell Park is Hiring!

        Working at Roswell Park will afford you incredible opportunities to work alongside some of the nation’s foremost clinicians and researchers to broaden your career experiences and be part of a team that eases the burden of cancer.

        • by

        • May 19, 2025

        • 1 min
        FDA Approves Device for Pancreas Care

        In the phase 3 PANOVA-3 trial, adding Tumor Treating Fields therapy to gemcitabine and nab-paclitaxel was associated with improved overall survival and delayed pain progression in adults with locally advanced pancreatic cancer.

        Immunoscore Refines CRC Prognosis, Therapy

        Despite a strong evidence base, the assay has not been widely implemented in routine clinical practice.